Drug giant Pfizer Inc. is back(pedaling) in the news again. This year it has “agreed” to a “request” from regulators to pull their arthritic pain medication, Bextra, off the market in Canada, the U.S. and Europe. The U.S. Food and Drug Administration has also ”asked” that all other COX-2 inhibitors, such as Celebrex (another Pfizer product), carry the strongest possible warnings about increased risk of heart attack and stroke.
(Hurting) Headitor’s note: Why did you think they called them pain killers?”